Do analysts rate HSCS or MODD?

HeartSciences currently has a consensus target price of $8.00, suggesting a potential upside of 334.78%. Given HeartSciences' stronger consensus rating and higher probable upside, research analysts plainly believe HeartSciences is more favorable than Modular Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HeartSciences 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Modular Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation and earnings, HSCS or MODD?

HeartSciences is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio HeartSciences N/A N/A -$8.77M -$4.94 N/A Modular Medical N/A N/A -$18.82M -$14.71 N/A

Is HSCS or MODD more profitable?

Modular Medical's return on equity of -245.85% beat HeartSciences' return on equity. Company Net Margins Return on Equity Return on Assets HeartSciences N/A -333.50% -140.18% Modular Medical N/A -245.85% -190.80%

Is IRIX or HSCS more profitable?

HeartSciences has a net margin of 0.00% compared to IRIDEX's net margin of -6.23%. HeartSciences' return on equity of -333.50% beat IRIDEX's return on equity. Company Net Margins Return on Equity Return on Assets IRIDEX -6.23% -1,204.74% -11.16% HeartSciences N/A -333.50% -140.18%

Do analysts recommend HSCS or TMDIF?

HeartSciences presently has a consensus price target of $8.00, indicating a potential upside of 334.78%. Given HeartSciences' stronger consensus rating and higher possible upside, research analysts clearly believe HeartSciences is more favorable than Titan Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HeartSciences 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is HSCS or TMDIF more profitable?

Titan Medical's return on equity of -82.31% beat HeartSciences' return on equity. Company Net Margins Return on Equity Return on Assets HeartSciences N/A -333.50% -140.18% Titan Medical N/A -82.31% -51.47%

Do analysts recommend HSCS or RVP?

HeartSciences currently has a consensus target price of $8.00, indicating a potential upside of 334.78%. Given HeartSciences' stronger consensus rating and higher possible upside, analysts plainly believe HeartSciences is more favorable than Retractable Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HeartSciences 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is HSCS or LFWD more profitable?

HeartSciences has a net margin of 0.00% compared to Lifeward's net margin of -123.66%. Lifeward's return on equity of -243.14% beat HeartSciences' return on equity. Company Net Margins Return on Equity Return on Assets HeartSciences N/A -333.50% -140.18% Lifeward -123.66% -243.14% -97.39%

HeartSciences (HSCS) Competitors

$1.84 0.00 (0.00%)

Closing price 06/18/2026 04:00 PM Eastern

Extended Trading

$1.92 +0.08 (+4.57%)

As of 04:27 AM Eastern

Compare

HSCS vs. MODD, IRIX, TMDIF, RVP, and LFWD

Should you buy HeartSciences stock or one of its competitors? MarketBeat compares HeartSciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with HeartSciences include Modular Medical (MODD), IRIDEX (IRIX), Titan Medical (TMDIF), Retractable Technologies (RVP), and Lifeward (LFWD). These companies are all part of the "medical equipment" industry.

How does HeartSciences compare to Modular Medical?

HeartSciences (NASDAQ:HSCS) and Modular Medical (NASDAQ:MODD) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, dividends and risk.

HeartSciences is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HeartSciences	N/A	N/A	-$8.77M	-$4.94	N/A
Modular Medical	N/A	N/A	-$18.82M	-$14.71	N/A

In the previous week, HeartSciences' average media sentiment score of 0.00 equaled Modular Medical'saverage media sentiment score.

Company	Overall Sentiment
HeartSciences	Neutral
Modular Medical	Neutral

Modular Medical's return on equity of -245.85% beat HeartSciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HeartSciences	N/A	-333.50%	-140.18%
Modular Medical	N/A	-245.85%	-190.80%

17.2% of HeartSciences shares are held by institutional investors. Comparatively, 27.5% of Modular Medical shares are held by institutional investors. 4.9% of HeartSciences shares are held by insiders. Comparatively, 7.1% of Modular Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

HeartSciences has a beta of 1.96, indicating that its share price is 96% more volatile than the broader market. Comparatively, Modular Medical has a beta of 0.31, indicating that its share price is 69% less volatile than the broader market.

HeartSciences currently has a consensus target price of $8.00, suggesting a potential upside of 334.78%. Given HeartSciences' stronger consensus rating and higher probable upside, research analysts plainly believe HeartSciences is more favorable than Modular Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HeartSciences	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Modular Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

HeartSciences beats Modular Medical on 7 of the 11 factors compared between the two stocks.

How does HeartSciences compare to IRIDEX?

IRIDEX (NASDAQ:IRIX) and HeartSciences (NASDAQ:HSCS) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, profitability, valuation, dividends and risk.

20.1% of IRIDEX shares are held by institutional investors. Comparatively, 17.2% of HeartSciences shares are held by institutional investors. 8.6% of IRIDEX shares are held by company insiders. Comparatively, 4.9% of HeartSciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

IRIDEX currently has a consensus target price of $3.00, indicating a potential upside of 162.01%. HeartSciences has a consensus target price of $8.00, indicating a potential upside of 334.78%. Given HeartSciences' higher probable upside, analysts plainly believe HeartSciences is more favorable than IRIDEX.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
HeartSciences	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

IRIDEX has a beta of 0.64, meaning that its share price is 36% less volatile than the broader market. Comparatively, HeartSciences has a beta of 1.96, meaning that its share price is 96% more volatile than the broader market.

IRIDEX has higher revenue and earnings than HeartSciences. IRIDEX is trading at a lower price-to-earnings ratio than HeartSciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IRIDEX	$52.67M	0.38	-$4.44M	-$0.19	N/A
HeartSciences	N/A	N/A	-$8.77M	-$4.94	N/A

In the previous week, IRIDEX had 1 more articles in the media than HeartSciences. MarketBeat recorded 1 mentions for IRIDEX and 0 mentions for HeartSciences. IRIDEX's average media sentiment score of 0.67 beat HeartSciences' score of 0.00 indicating that IRIDEX is being referred to more favorably in the media.

Company	Overall Sentiment
IRIDEX	Positive
HeartSciences	Neutral

HeartSciences has a net margin of 0.00% compared to IRIDEX's net margin of -6.23%. HeartSciences' return on equity of -333.50% beat IRIDEX's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IRIDEX	-6.23%	-1,204.74%	-11.16%
HeartSciences	N/A	-333.50%	-140.18%

Summary

IRIDEX beats HeartSciences on 8 of the 13 factors compared between the two stocks.

How does HeartSciences compare to Titan Medical?

HeartSciences (NASDAQ:HSCS) and Titan Medical (NASDAQ:TMDIF) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, dividends, institutional ownership, media sentiment, risk and profitability.

Titan Medical has higher revenue and earnings than HeartSciences. HeartSciences is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HeartSciences	N/A	N/A	-$8.77M	-$4.94	N/A
Titan Medical	$17.63M	1.09	$6.95M	$0.05	3.38

HeartSciences presently has a consensus price target of $8.00, indicating a potential upside of 334.78%. Given HeartSciences' stronger consensus rating and higher possible upside, research analysts clearly believe HeartSciences is more favorable than Titan Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HeartSciences	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, HeartSciences' average media sentiment score of 0.00 equaled Titan Medical'saverage media sentiment score.

Company	Overall Sentiment
HeartSciences	Neutral
Titan Medical	Neutral

HeartSciences has a beta of 1.96, meaning that its share price is 96% more volatile than the broader market. Comparatively, Titan Medical has a beta of 1.26, meaning that its share price is 26% more volatile than the broader market.

Titan Medical's return on equity of -82.31% beat HeartSciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HeartSciences	N/A	-333.50%	-140.18%
Titan Medical	N/A	-82.31%	-51.47%

17.2% of HeartSciences shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 4.9% of HeartSciences shares are owned by insiders. Comparatively, 0.0% of Titan Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

HeartSciences and Titan Medical tied by winning 6 of the 12 factors compared between the two stocks.

How does HeartSciences compare to Retractable Technologies?

HeartSciences (NASDAQ:HSCS) and Retractable Technologies (NYSE:RVP) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, earnings, valuation, institutional ownership, risk, profitability and analyst recommendations.

HeartSciences has a beta of 1.96, meaning that its stock price is 96% more volatile than the broader market. Comparatively, Retractable Technologies has a beta of 1.27, meaning that its stock price is 27% more volatile than the broader market.

17.2% of HeartSciences shares are owned by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are owned by institutional investors. 4.9% of HeartSciences shares are owned by company insiders. Comparatively, 59.5% of Retractable Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

HeartSciences has a net margin of 0.00% compared to Retractable Technologies' net margin of -41.11%. Retractable Technologies' return on equity of -17.15% beat HeartSciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HeartSciences	N/A	-333.50%	-140.18%
Retractable Technologies	-41.11%	-17.15%	-9.33%

HeartSciences currently has a consensus target price of $8.00, indicating a potential upside of 334.78%. Given HeartSciences' stronger consensus rating and higher possible upside, analysts plainly believe HeartSciences is more favorable than Retractable Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HeartSciences	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Retractable Technologies has higher revenue and earnings than HeartSciences. Retractable Technologies is trading at a lower price-to-earnings ratio than HeartSciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HeartSciences	N/A	N/A	-$8.77M	-$4.94	N/A
Retractable Technologies	$37.15M	0.54	-$7.01M	-$0.21	N/A

In the previous week, Retractable Technologies had 1 more articles in the media than HeartSciences. MarketBeat recorded 1 mentions for Retractable Technologies and 0 mentions for HeartSciences. HeartSciences' average media sentiment score of 0.00 equaled Retractable Technologies'average media sentiment score.

Company	Overall Sentiment
HeartSciences	Neutral
Retractable Technologies	Neutral

Summary

HeartSciences and Retractable Technologies tied by winning 7 of the 14 factors compared between the two stocks.

How does HeartSciences compare to Lifeward?

HeartSciences (NASDAQ:HSCS) and Lifeward (NASDAQ:LFWD) are both small-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, media sentiment, analyst recommendations, dividends, earnings and profitability.

In the previous week, HeartSciences' average media sentiment score of 0.00 equaled Lifeward'saverage media sentiment score.

Company	Overall Sentiment
HeartSciences	Neutral
Lifeward	Neutral

HeartSciences has a beta of 1.96, indicating that its share price is 96% more volatile than the broader market. Comparatively, Lifeward has a beta of 0.36, indicating that its share price is 64% less volatile than the broader market.

HeartSciences currently has a consensus target price of $8.00, indicating a potential upside of 334.78%. Lifeward has a consensus target price of $10.00, indicating a potential upside of 44.72%. Given HeartSciences' stronger consensus rating and higher probable upside, equities research analysts plainly believe HeartSciences is more favorable than Lifeward.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HeartSciences	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Lifeward	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67

HeartSciences has a net margin of 0.00% compared to Lifeward's net margin of -123.66%. Lifeward's return on equity of -243.14% beat HeartSciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HeartSciences	N/A	-333.50%	-140.18%
Lifeward	-123.66%	-243.14%	-97.39%

HeartSciences has higher earnings, but lower revenue than Lifeward. HeartSciences is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HeartSciences	N/A	N/A	-$8.77M	-$4.94	N/A
Lifeward	$22.03M	0.88	-$19.91M	-$19.66	N/A

17.2% of HeartSciences shares are held by institutional investors. Comparatively, 26.8% of Lifeward shares are held by institutional investors. 4.9% of HeartSciences shares are held by company insiders. Comparatively, 1.5% of Lifeward shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

HeartSciences beats Lifeward on 7 of the 12 factors compared between the two stocks.

Get HeartSciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HSCS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HSCS vs. The Competition

Export

Metric	HeartSciences	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$5.85M	$1.58B	$6.41B	$12.59B
Dividend Yield	N/A	N/A	2.68%	5.81%
P/E Ratio	-0.37	77.84	24.62	24.44
Price / Sales	N/A	7.59	527.33	111.09
Price / Cash	N/A	23.77	27.92	37.84
Price / Book	10.22	5.12	10.70	6.60
Net Income	-$8.77M	-$54.76M	$3.57B	$337.10M
7 Day Performance	N/A	1.98%	0.44%	-0.13%
1 Month Performance	-7.07%	-1.50%	0.01%	1.75%
1 Year Performance	-51.06%	-0.52%	29.35%	36.12%

HeartSciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HSCS HeartSciences	2.2652 of 5 stars	$1.84 flat	$8.00 +334.8%	-51.1%	$5.85M	N/A	N/A	10
MODD Modular Medical	0.6029 of 5 stars	$4.46 -9.2%	N/A	-77.4%	$22.89M	N/A	N/A	20	Gap Down
IRIX IRIDEX	2.0799 of 5 stars	$1.17 -1.7%	$3.00 +156.4%	+22.7%	$20.71M	$52.67M	N/A	120	Gap Up
TMDIF Titan Medical	N/A	$0.18 -7.2%	N/A	-21.8%	$20.44M	$17.63M	N/A	50
RVP Retractable Technologies	N/A	$0.67 +1.5%	N/A	+5.9%	$20.05M	$37.15M	N/A	240

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HSCS) was last updated on 6/22/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

HeartSciences (HSCS) Competitors

HSCS vs. MODD, IRIX, TMDIF, RVP, and LFWD

How does HeartSciences compare to Modular Medical?

Summary

How does HeartSciences compare to IRIDEX?

Summary

How does HeartSciences compare to Titan Medical?

Summary

How does HeartSciences compare to Retractable Technologies?

Summary

How does HeartSciences compare to Lifeward?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HSCS vs. The Competition

HeartSciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

HeartSciences (HSCS) Competitors

HSCS vs. MODD, IRIX, TMDIF, RVP, and LFWD

How does HeartSciences compare to Modular Medical?

Which has preferable valuation and earnings, HSCS or MODD?

Does the media refer more to HSCS or MODD?

Is HSCS or MODD more profitable?

Do insiders & institutionals have more ownership in HSCS or MODD?

Which has more volatility & risk, HSCS or MODD?

Do analysts rate HSCS or MODD?

Summary

How does HeartSciences compare to IRIDEX?

Do insiders and institutionals believe in IRIX or HSCS?

Do analysts rate IRIX or HSCS?

Which has more volatility and risk, IRIX or HSCS?

Which has higher valuation and earnings, IRIX or HSCS?

Does the media favor IRIX or HSCS?

Is IRIX or HSCS more profitable?

Summary

How does HeartSciences compare to Titan Medical?

Which has preferable valuation & earnings, HSCS or TMDIF?

Do analysts recommend HSCS or TMDIF?

Does the media favor HSCS or TMDIF?

Which has more volatility & risk, HSCS or TMDIF?

Is HSCS or TMDIF more profitable?

Do insiders & institutionals believe in HSCS or TMDIF?

Summary

How does HeartSciences compare to Retractable Technologies?

Which has more risk and volatility, HSCS or RVP?

Do institutionals and insiders believe in HSCS or RVP?

Is HSCS or RVP more profitable?

Do analysts recommend HSCS or RVP?

Which has stronger earnings and valuation, HSCS or RVP?

Does the media favor HSCS or RVP?

Summary

How does HeartSciences compare to Lifeward?

Does the media favor HSCS or LFWD?

Which has more risk and volatility, HSCS or LFWD?

Do analysts rate HSCS or LFWD?

Is HSCS or LFWD more profitable?

Which has stronger earnings & valuation, HSCS or LFWD?

Do insiders & institutionals believe in HSCS or LFWD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HSCS vs. The Competition

HeartSciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools